ABCB5 and recessive dystrophic epidermolysis bullosa: Thus, Kiritsi D. et al. (2021) conducted the international single-arm clinical trial with intravenous infusions of ABCB5+ MSCs to RDEB patients (phases I/IIa Clinicaltrials.gov NCT03529877; EudraCT 2018-001009-98).